When was Cernostics founded?

Cernostics was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is Cernostics located?

Cernostics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania.

How many employees does Cernostics have?

As of Dec 31, 2022, Cernostics has 16 employees, reflecting a 15% year-over-year growth in headcount.

Is Cernostics a funded company?

Cernostics is a funded company, having raised a total of $14.2M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 12, 2009.

How much is Cernostics worth?

The last known valuation of Cernostics was $***** as of Dec 16, 2021.

When was the latest funding round of Cernostics?

Cernostics' latest funding was a $***** Series B round on Mar 21, 2018, with participation from 1 investor. Its primary sector is Gastroenterology. In United States, the Gastroenterology sector has seen $541M in funding in 2026 to date.

Where does Cernostics rank among its competitors?

Cernostics ranks 4th amongst 6 active competitors, of which 2 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was PAVmed, which secured $30M in Feb, 2026.

Who are the top competitors of Cernostics?

Cernostics' top competitors include Cyted, PAVmed and Lucid Diagnostics. Among them, PAVmed secured the most recent funding round in February, 2026.

Cernostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Cernostics is focused on delivering cancer diagnostic and prognostic tests through a unique approach to tissue analysis. Cernostics’s tissue systems biology approach simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide, while preserving and evaluating tissue structure. Cernostics’ lead product under development, TissueCypher Barrett’s Esophagus Assay, uses whole slide digital imaging technology to produce comprehensive risk prediction for the development of esophageal cancer in patients with Barrett’s Esophagus.

Website: cernostics.com
Social
Registered Address: Pittsburgh, Pennsylvania

Key Metrics

Founded Year

2008

Location

Pittsburgh, United States

Stage

Acquired

Total Funding

$14.2M in 10 rounds

Latest Funding Round

Series B, Mar 21, 2018, $*****

Last Known Valuation

$***** as on Dec 16, 2021

Investors

Ben Franklin Technology Partners & 6 more

Ranked

4^th among 6 active competitors

Employee Count

16 as on Dec 31, 2022

Similar Companies

Cyted & 6 more

Exit Details

Acquired by Castle Biosciences (Oct 22, 2021)

View Cernostics' full profile

Cernostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cernostics, Inc CIN: 263438110 , United States, Active	Dec 31, 1999	-	16 (As on Dec 31, 2021)	-

Cernostics got acquired by Castle Biosciences on Oct 22, 2021.

Click here to take a look at Cernostics's acquisition in detail

Cernostics has raised a total funding of $14.2M over 10 rounds. Its first funding round was on Nov 12, 2009. Its latest funding round was a Series B round on Mar 21, 2018 for $*****. 1 investor participated in its latest round. Cernostics has 7 institutional investors.

Here is the list of recent funding rounds of Cernostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2018	3179468	Series B	8162223	8715035	2452674	3661232
Aug 31, 2016	4980482	Series B	4438363	1486044	3288080	Novitas Capital
Oct 29, 2015	9173045	Grant (prize money)	5838035	9275012	1138395	NIH

Access funding benchmarks and valuations. Sign up today!

View details of Cernostics's funding rounds and investors

Cernostics' employee count trend

Cernostics has 16 employees as of Dec 22. The total employee count is 14.0% more than what it was in Dec 21. Here is Cernostics's employee count trend over the years:

Uncover Cernostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cernostics include Cyted, PAVmed and Lucid Diagnostics. Here is the list of Top 10 competitors of Cernostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cyted 2018, Cambridge (United Kingdom), Series B	Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all	$50.4M	Advent Life Sciences, EQT & 3 others	57/100
2nd	PAVmed 2014, New York City (United States), Public	Developer of medical devices and biomarkers to detect various diseases	$845K	HHS, WI Harper Group	53/100
3rd	Lucid Diagnostics 2018, New York City (United States), Public	Developer of diagnostic kit for oesophagal cancer	-	-	53/100
4th	Cernostics 2008, Pittsburgh (United States), Acquired	Diagnostic and prognostic tests for Esophageal Cancer	$14.2M	UPMC, Novitas Capital & 5 others	49/100
5th	BeamLine Diagnostics 2015, London (United Kingdom), Deadpooled	Provider of bedside pre-screening technology for cancer	$1.08M	Angels in MedCity, London Co-Investment Fund ... & 2 others	38/100
6th	Previse 2018, Baltimore (United States), Acquired	Provider of diagnostic tests for the detection of cancer	$5.39M	NIDDK	35/100
7th	Capsulomics 2018, Baltimore (United States), Seed	Developer of methylation based diagnostic tests for esophageal cancer risk	$50K	TEDCO, Gaingels & 1 others	25/100
8th	CapNostics 2013, Newtown Square (United States), Acqui-Hired	FDA cleared swallowable screening device for endoscopic procedures.	-	PAVmed	16/100